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a  b  s  t  r  a  c  t
Stem  cells  represent  a potential  cellular  resource  in the  development  of  regenerative  medicine  approaches
to  the  treatment  of  pathologies  in which  speciﬁc  cells  are  degenerated  or  damaged  by  genetic  abnormal-
ity,  disease,  or  injury.  Securing  sufﬁcient  supplies  of cells suited  to the demands  of cell transplantation,
however,  remains  challenging,  and  the establishment  of  safe  and  efﬁcient  cell  banking  procedures  is an
important  goal.  Cryopreservation  allows  the storage  of stem  cells  for  prolonged  time  periods  while  main-
taining them  in  adequate  condition  for use  in  clinical  settings.  Conventional  cryopreservation  systems
include  slow-freezing  and vitriﬁcation  both  have  advantages  and  disadvantages  in terms  of cell  viability
and/or  scalability.  In the present  study,  we  developed  an  advanced  slow-freezing  technique  using  a  pro-
grammed  freezer  with  a  magnetic  ﬁeld  called  Cells  Alive  System  (CAS)  and  examined  its  effectiveness
on  human  induced  pluripotent  stem  cell-derived  neural  stem/progenitor  cells  (hiPSC-NS/PCs).  This  sys-uman iPSC-derived neural
tem/progenitor cells (hiPSC-NS/PCs)
eurosphere
llogeneic transplantation
pinal cord injury (SCI)
entral nervous system (CNS) disorder
tem signiﬁcantly  increased  cell viability  after  thawing  and  had  less  impact  on  cellular  proliferation  and
differentiation.  We  further  found  that  frozen-thawed  hiPSC-NS/PCs  were  comparable  with non-frozen
ones  at the transcriptome  level.  Given  these  ﬁndings,  we  suggest  that  the  CAS is useful  for hiPSC-NS/PCs
banking  for  clinical  uses  involving  neural  disorders  and  may  open  new  avenues  for  future  regenerative
medicine.
©  2015  The  Authors.  Published  by Elsevier  Ireland  Ltd.  This  is an  open  access  article  under  the CC. Introduction
A growing body of evidence indicates that stem cells may  serve
s a useful source for regenerative medicine applications target-
ng certain refractory diseases. Neural stem and progenitor cells
NS/PCs) derived from human fetus and/or embryonic stem cells
ESCs) represent one potential source of transplantation approach
or neurodegenerative diseases and neurotraumatic injuries, such
s brain infarction and spinal cord injury (SCI). While NS/PCs can
e incorporated into host tissues and restore nervous system func-
ionality (Nakamura and Okano, 2013; Okano et al., 2013), the
arvesting of such cells from a human fetus confronts legal and
∗ Corresponding authors.
E-mail addresses: masa@a8.keio.jp (M.  Nakamura), hidokano@a2.keio.jp
H. Okano).
ttp://dx.doi.org/10.1016/j.neures.2015.11.011
168-0102/© 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open access
c-nd/4.0/)BY-NC-ND  license.  (http://creativecommons.org/licenses/by-nc-nd/4.0/)
ethical challenges in many countries including Japan. Since the
development of a new technique for establishing human induced
pluripotent stem cells (hiPSCs) from somatic tissues (Takahashi
et al., 2007), hiPSCs have become an attractive alternative cell
source due to their ease of generation and comparative lack of
ethical baggage.
In Japan, there is an ongoing project to establish a hiPSCs bank
to provide cells for use in allogeneic transplantation (Nakatsuji
et al., 2008; Okano and Yamanaka, 2014; Okita et al., 2011). We
have previously reported the effectiveness of transplanting hiPSC-
derived NS/PCs (hiPSC-NS/PCs) for SCI in rodents and non-human
primates (Imaizumi et al., 2012; Kobayashi et al., 2012; Nori et al.,
2011). Because it takes about six months to establish hiPSC-NS/PCs
derived from an SCI patient’s autologous somatic cells (Okada et al.,
2008), at present it is impossible to perform auto-graft of iPSC-
NS/PCs within the optimal therapeutic time window for sub-acute
SCI (from 2 to 4 weeks after injury) (Nishimura et al., 2014; Okano
 article under the CC BY-NC-ND license. (http://creativecommons.org/licenses/by-
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Fig. 1. Temperature of the cryopreservation solution. (A) Freezing temperature of
cryopreservation solution (STEM-CELLBANKER). Lowering the setting temperature
gradually, exothermic reaction was observed when actual temperature became
about −8.5 ◦C. It indicates that freezing starts at this temperature. (B) Setting of the
CAS programmed freezer and changes of the actual temperature. After the conﬁr-
mation of the freezing temperature, we  set the temperature of the CAS programmedY. Nishiyama et al. / Neurosc
nd Yamanaka, 2014). To extend our results into potential clinical
pplications, therapeutic strategies will heavily rely on allogeneic
ransplantation of hiPSC-NS/PCs. We  note here that hiPSC-NS/PCs
ay need to be stored properly to achieve favorable outcomes
fter transplantation. Cryopreservation makes it possible to store
ells for prolonged time periods adequate for the clinical setting,
lthough hiPSC-NS/PCs should be cryopreserved with high survival
ates and minimal impact on cellular properties such as prolif-
ration and developmental potency after freezing and thawing.
ryopreserved cells intended for clinical use must further be val-
dated at given time points to avoid signiﬁcant adverse outcomes
uch as failure to engraft into recipient tissue. However, few studies
o date have evaluated NS/PC properties before and after freezing
nd thawing (Hancock et al., 2000; Ma  et al., 2010; Milosevic et al.,
005; Paynter, 2008; Tan et al., 2007).
Currently preferred procedures for preparing cryopreserved
ells are classiﬁed into two general types: slow-freezing and vitri-
cation. The slow-freezing procedure has the beneﬁcial aspect of
nabling the preparation of large quantities of vials at one time,
hile the vitriﬁcation method is superior in terms of cell survival.
ecently, the Cells Alive System (CAS) (ABI corporation Ltd., Abiko,
apan) was developed as a novel freezing technology and it has
een used in the cryopreservation of various kinds of cells, includ-
ng murine osteoblasts, rat bone tissue fragments, rat mesenchymal
tem cells (MSCs), human periodontal ligament cells, and human
S cells (Abedini et al., 2011; Kaku et al., 2010, 2014, 2015; Kojima
t al., 2013, 2015; Koseki et al., 2013; Lin et al., 2013) and proven
o be a more effective method for cell preservation. However, it
emains unclear whether this procedure is applicable to the bank-
ng of hiPSC-NS/PCs as well.
In this study, we used CAS to cryopreserve hiPSC-NS/PCs and
xamined the effects of cryopreservation process on hiPSC-NS/PCs.
e determined a simple, optimized method designed for clinical
se of these cells with improved cell viability without detrimental
mpact on cell properties using this system.
. Materials and methods
.1. Cell culture
The hiPSCs (clone 201B7) were cultured and maintained as
escribed previously (Kobayashi et al., 2012; Nori et al., 2011;
akahashi et al., 2007). To perform neural induction of hiPSCs,
e generated embryoid bodies (EBs) as described previously
Kobayashi et al., 2012; Nori et al., 2011). EBs were then enzymat-
cally dissociated into single cells and cultured in suspension in
erum-free media hormone mix  (MHM)  media for 10–14 days to
llow the formation of neurospheres (Kobayashi et al., 2012). Neu-
ospheres were dissociated into single cells and then cultured in
he same manner for passage. The diameters of neurospheres were
easured using inverted microscope (IX73, OLYMPUS Corporation,
okyo, Japan). To evaluate cell viability, cells were enzymatically
issociated immediately after thawing in a water bath at 37 ◦C for
 min  and viable cells were counted by trypan blue exclusion test.
ive visual ﬁelds chosen at random with a 4× objective lens were
sed to identify the diameter of hiPSC-NS/PCs spheres.
.2. Cell freezing
After partially dissociating the hiPSC-NS/PCs, we  counted the
iable cells using the trypan blue exclusion test at three or six days
fter the last passage. A total of 2 or 5 × 106 cells were placed as neu-
ospheres in a cryo-tube (Nunc CryoTubes, Thermo Fisher Scientiﬁc
nc., MA,  USA) with 1 ml  cryopreservation solution (STEMCELL-
ANKER, ZENOAQ, Fukushima, Japan). For cryopreservation, thefreezer as shown in gray line. It is hold for 5 min at 4 ◦C, for 15 min  at −7 ◦C (super-
cooling state) and plunged to −70 ◦C. In this setting, it took about 130 min  to became
−70 ◦C.
vials were placed in the CAS programmed freezer containing a
magnetic ﬁeld or a freezing container (Nalgene Mr.  Frosty, Thermo
Fisher Scientiﬁc, MA,  USA). The alternating magnetic ﬁeld with an
induced electric ﬁeld generated by the CAS freezer causes cells
and water molecules to vibrate by a non-thermal mechanism and
prevents the formation of intracellular ice crystals. As a result,
improvement of cell viability would be achieved (Kaku et al., 2010,
2012, 2015). The electric current and frequency were adjusted to
change the intensity of the magnetic ﬁeld in the CAS. The freezing
protocol was as follows: 4 ◦C for 5 min, −7 ◦C for 15 min, plunged to
−70 ◦C (shown as the gray line in Fig. 1B); the electric current of CAS
was adjusted as follows: 0.5, 0.4 and 0.3 A. We  set the frequency of
CAS to 30 Hz. To measure the actual temperature, thermocouple
thermometer (testo 735-2, Testo, Kanagawa, Japan) with a sheath-
type ﬂexible probe was  used in every minute and it was repeated
at least three times.
2.3. Immunocytochemistry
To perform immunocytochemistry in spheres, we centrifuged
the spheres at 1000 rpm for 5 min. Cells were collected using iPGell
(GenoStaff, Tokyo, Japan) and postﬁxed for 1 h in 4% paraformalde-
hyde (PFA), soaked 4 h in 10% sucrose, 4 h in 20% sucrose, and
then overnight in 30% sucrose, following the manufacturer’s
instructions. We  then embedded the spheres in Optimal Cutting
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Table 1
The intensity of the magnetic ﬁeld in the CAS.
Electric current (A) 0.3 0.4 0.5
Frequency (Hz) 30 30 30
Magnetic force (mT) 0.22–0.29 0.30–0.40 0.37–0.502 Y. Nishiyama et al. / Neurosc
emperature compound (Sakura Finetek Japan Co., Ltd., Tokyo,
apan), and sectioned them at 14 m on a cryostat (Leica CM3050 S,
eica Microsystems, IL, USA). These sections were stained with the
ollowing primary antibodies: anti-Ki-67 (rabbit IgG, 1:200, Novo-
astra, Newcastle upon Tyne, UK), anti-SOX2 (Mouse IgG, 1:500,
&D Systems, MN,  USA). Nuclei were stained with Hoechst 33258
10 g/mL; Sigma Chemical Co., MO,  USA). Images were obtained
y a confocal laser scanning microscope (LSM780; Carl Zeiss, Jena,
ermany). At least seven visual ﬁelds chosen at random with a 20×
bjective lens were used to quantify the Ki-67 positive cells and
OX2 positive cells.
To assay the degree of differentiation by immunostaining,
iPSC-NS/PCs were dissociated into single cells, plated on poly-l-
rnithine/ﬁbronectin-coated cover glasses, and allowed to undergo
pontaneous differentiation for 10 days, following a previously
eported method (Imaizumi et al., 2012; Okada et al., 2008). The
ells were ﬁxed for 10 min  in 8% PFA, then 15 min  in 4% PFA.
ells were stained with the following primary antibodies: anti-Hu
human IgG, 1:1000, a gift from Prof. Robert Darnell, The Rocke-
eller University, New York, NY, USA), anti-glial ﬁbrillary acidic
rotein (GFAP) (rabbit IgG, 1:200, Dako, CA, USA), anti-2′,3′-cyclic
ucleotide 3′-phosphohydrolase (CNPase) (mouse IgG; 1:1000,
igma Chemical Co., MO,  USA), anti-SOX2 (Mouse IgG, 1:500, R&D
ystems, MN,  USA), anti--tubulin isotype III (III tubulin, Tuj1,
ouse IgG, 1:1000, Sigma Chemical Co., MO,  USA). Nuclei were
tained with Hoechst 33258 (10 g/mL; Sigma Chemical Co., MO,
SA). Images were obtained by a confocal laser scanning micro-
cope (LSM780; Carl Zeiss, Jena, Germany). At least ﬁve visual ﬁelds
hosen at random with a 20× objective lens were used to quantify
he Hu-positive cells and SOX2-positive cells.
.4. Microarray analysis
The samples were placed in TRIzol (Invitrogen, CA, USA) and
mmediately frozen. Total RNA was isolated using Qiagen RNeasy
it (Qiagen Inc., Hilden, Germany). Microarray analysis was per-
ormed using Affymetrix GeneChip technology (Affymetrix Japan,
okyo, Japan). Total RNA (100 ng) was reverse transcribed, biotin
abeled, and hybridized. Hybridization was performed using the
ffymetrix GeneChip 3′IVT PLUS Reagent Kit (Affymetrix Japan,
okyo, Japan) for 16 h at 45 ◦C. Arrays were scanned using a
eneChip Scanner 3000 (Affymetrix Japan, Tokyo, Japan). Data
nalysis was performed using Expression Analysis Data Analysis
undamentals (Affymetrix Japan, Tokyo, Japan). Signal detection,
uantiﬁcation and normalization were performed using the MAS5
lgorithm at the default settings, following the manufacturer’s
nstructions. Principal component analysis (PCA) and hierarchical
lustering were performed using GeneSpring GX (Agilent Technolo-
ies, CA, USA).
.5. Statistical analysis
All data are reported as the mean ± SEM. An unpaired two-
ailed Student’s t test was used to assess the diameter of the
eurospheres, the proliferation and differentiation efﬁcacy of
iPSC-NS/PCs between non-frozen and frozen-thawed. One-way
NOVA, followed by the Scheffe’s multiple comparison test was
sed for the survival. In each case, *P < 0.05 and **P < 0.01 were
onsidered to be statistically signiﬁcant.
. Results.1. Validation of CAS for cryopreservation of hiPSC-NS/PCs
Since the CAS is reported to be effective for cryopreserva-
ion of various cell types, including murine osteoblasts, rat boneThe intensity of the magnetic ﬁeld in the CAS when the electric current is 0.3 A, 0.4 A
and  0.5 A is 0.22–0.29 mT, 0.30–0.40 mT and 0.37–0.50 mT, respectively.
tissue fragments, rat MSCs, human periodontal ligament cells,
human erythrocytes, and human ESCs (hESCs) (Abedini et al., 2011;
Kaku et al., 2010, 2014, 2015; Kojima et al., 2013, 2015; Koseki
et al., 2013; Lin et al., 2013), we  sought to apply this method-
ology to the cryopreservation of NS/PCs derived from hiPSCs.
We ﬁrst compared the actual temperature of the cryopreserva-
tion solution in the CAS with the setting temperature to validate
the system. We  determined freezing temperature by exothermic
reaction. We  measured the freezing temperature four times and
found out to be −8.5 to −16.0 ◦C. Fig. 1A shows one of the exam-
ples to measure the freezing temperature. To pass more rapidly
through the temperature zone at which ice crystals form, we set
the sample temperature at −7 ◦C, which was just above the freez-
ing temperature, known as a “super-cooling state”. We  maintained
this temperature for 15 min  to preserve all samples in an indi-
vidual vial at uniform temperature. The actual temperature is
shown in Fig. 1B. The intensity of the magnetic ﬁeld in the CAS
under three conditions we  examined in this study is shown in
Table 1.
3.2. The CAS improved survival rate of frozen hiPSC-NS/PCs
To examine the impact on cell survival during cryopreservation,
we examined the survival rate of hiPSC-NS/PCs immediately after
thawing in a water bath at 37 ◦C for 2 min. Frozen-thawed hiPSC-
NS/PCs were partially dissociated and stained by 0.5% trypan blue to
estimate the number of dead cells among total cell population. We
set up experiments in two conditions for cell preservation: frozen
at densities of 2 × 106 cells/ml (lower density) and 5 × 106 cells/ml
(higher density). Cell preservation was performed three or six
days after the last passage. For the setting of the CAS, we  com-
pared three different settings (0.5, 0.4 and 0.3 A) in the following
experiment.
The survival rates of hiPSC-NS/PCs under several conditions
are shown in Fig. 2A and B, indicating that the CAS did not have
much impact on cell viability compared to classical slow-freezing
approach. There were signiﬁcant differences in cell viability
between the CAS at 0.4 A (0.30–0.40 mT)  and 0.3 A (0.22–0.29 mT)
and the freezing container at all conditions examined. The high-
est cell viability was  achieved when hiPSC-NS/PCs were frozen at
2 × 106 cells/ml six days after the last passage using the CAS at 0.4 A
(0.30–0.40 mT). Thus, we  decided to use this setting for further
experiments, and describe the characterization of cryopreserved
hiPSC-NS/PCs in the following section.
We next assessed the diameter of the non-frozen neurospheres
and frozen-thawed neurospheres derived from hiPSC-NS/PCs,
which were frozen at the density of 2 × 106 cells/ml three and six
days after the last passage using the CAS at 0.4 A (0.30–0.40 mT)  or
the freezing container. These results indicated a signiﬁcant size dif-
ference in neurospheres frozen using these two methods, as shown
in Fig. 2C and D.
We  speculated that the reduction of the diameter after thawing
was due to cell death, caused by the mechanical stress of freezing
and thawing. The difference of the diameter after thawing between
the CAS and freezing container was also due to cell death and
mechanical stress. Freezing by CAS may  thus confer less stress to
cells than freezing by conventional container.
Y. Nishiyama et al. / Neuroscience Research 107 (2016) 20–29 23
Fig. 2. Cell survival and the diameter of neurospheres. (A, B) Cell survival under the several conditions of freezing. Cells were frozen at 3 days after the last passage (Day 3)
(A)  and 6 days after the last passage (Day 6) (B). The number of frozen cells was 2 × 106 cells/ml and 5 × 106 cells/ml. The best viability was 66.6% when hiPSC-NS/PCs were
frozen  at Day 6 and at the density of 2 × 106 cells/ml using the CAS programmed freezer with a 0.30–0.40 mT magnetic ﬁeld (0.4 A). The CAS programmed freezer increased
the  cell survival after freezing and thawing, especially with a 0.30–0.40 mT magnetic ﬁeld (0.4 A). There were signiﬁcant differences between 0.22 and 0.29 mT (0.3 A),
0.30–0.40 mT  (0.4 A) and the freezing container in any timing and density. (C, D) The diameter of non-frozen and frozen-thawed neurospheres. We assessed the diameter
of  the non-frozen neurospheres and frozen-thawed neurospheres including hiPSC-NS/PCs, which were frozen at the density of 2 × 106 cells/ml at Day 3 (C) and Day  6 (D)
using  the CAS programmed freezer with a 0.30–0.40 mT  magnetic ﬁeld (0.4 A) or the freezing container. There was a signiﬁcant difference in the diameter of frozen-thawed
neurospheres between the CAS programmed freezer and freezing container at both Day 3 and Day 6.
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ast  passage. There was no signiﬁcant difference in proliferation ability between no
.3. Proliferative property of hiPSC-NS/PCs were unchanged using
he CAS
Based on these ﬁndings, we assessed the proliferation ability of
hese frozen-thawed hiPSC-NS/PCs, which were cryopreserved at
ower density using the CAS at 0.4 A (0.30–0.40 mT)  3 or 6 days after
he last passage and compared with non-frozen cells. We  assessed
he proliferation ability of non-frozen and frozen-thawed neuro-
pheres derived from hiPSC-NS/PCs by immunostaining for Ki-67
nd SOX2 (Fig. 3A and B). There were no signiﬁcant differences
n proliferation ability between the non-frozen and frozen-thawed
iPSC-NS/PCs under the speciﬁc conditions described above (Fig. 3C
nd D).
.4. Differentiation ability was maintained in cryopreserved
iPSC-NS/PCs
To assess the differentiation ability of non-frozen and frozen-
hawed hiPSC-NS/PCs, we induced differentiation of hiPSC-NS/PCs frozen at 3 days and 6 days after the last passage. (A, B) Immunostaining for Ki-67
 and frozen-thawed neurospheres which were frozen at 3 days and 6 days after the
en and frozen-thawed cells. Scale bar = 100 m.
for 10 days in vitro and, subsequently assessed them for differ-
entiation ability to examine the expression of lineage speciﬁc
markers; Hu for neurons, GFAP for astrocytes, CNPase for oligo-
dendrocytes, and SOX2 for undifferentiated neural progenitor cells.
We prepared frozen hiPSC-NS/PCs, which had been frozen at lower
density three or six days after the last passage. As shown in
Fig. 4A and B, these hiPSC-NS/PCs had a trend to predominantly
differentiate into Hu-positive neurons and they could produce less
glial cells including GFAP-positive astrocytes and CNPase-positive
oligodendrocytes, which are known differentiation properties of
hiPSC-NS/PCs in vitro (Kobayashi et al., 2012). Unexpectedly, we
noticed that signiﬁcant number of Hu-positive cells also expressed
SOX2, indicating that majority of neurons generated in our experi-
mental paradigm were immature and hiPSC-NS/PCs probably need
more time to differentiate into mature neurons. However, at least,
we could conﬁrm that freezing-thaw process did not affect ini-
tial neuronal differentiation program, which are most important
in terms of clinical application of hiPSC-NS/PCs to neurological
diseases. To conﬁrm the differentiation ability of hiPSC-NS/PCs
Y. Nishiyama et al. / Neuroscience Research 107 (2016) 20–29 25
Fig. 4. Immunostaining of the non-frozen and frozen-thawed hiPSC-NS/PCs. The hiPSC-NS/PCs were frozen at 3 days and 6 days after the last passage. Neural induction was
performed for 10 days in vitro. (A, B) Immunostaining for Hu to detect neurons and SOX2 to detect undifferentiated cells with a high magniﬁcation (40× objective lens was
used).  (C) Immunostaining for III tubulin to detect neurons. (D, E) Quantitative analysis of Hu and SOX2-positive cells of the non-frozen and frozen-thawed hiPSC-NS/PCs,
which were frozen at 3 days and 6 days after the last passage. These cells dominantly differentiated into Hu-positive neurons, but less GFAP-positive cells and CNPase-positive
cells.  There were no signiﬁcant differences in the percentages of Hu and SOX2-positive cells between non-frozen and frozen-thawed cells. Scale bar = 50 m.
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Fig. 5. Principal component analysis and hierarchical clustering of the transcriptome analysis. (A) Principal component analysis in hiPSCs, non-frozen hiPSC-NS/PCs, which
were  3 days (Day 3) or 6 days after the last passage (Day 6) and frozen-thawed hiPSC-NS/PCs, which were frozen at Day 3 or Day 6 using the CAS programmed freezer or the
freezing container. The samples of hiPSCs and hiPSC-NS/PCs frozen at Day 3 or Day 6 were clearly separated and the samples of frozen-thawed hiPSC-NS/PCs were closely
c  Hiera
e Day 6
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tlustered with non-frozen sample in each freezing timing and freezing method. (B)
xpression proﬁle of frozen-thawed hiPSC-NS/PCs, which were frozen at Day 3 and 
losely  clustered in each freezing timing and freezing method.
nto neurons, we also used III tubulin marker and foundIII
ubulin-positive neurons in all conditions (Fig. 4C). There were no
igniﬁcant differences in the percentages of Hu and SOX2-positive
ells between the non-frozen and the frozen-thawed cells under
he speciﬁc condition as described above (Fig. 4D and E).
.5. Transcriptome analysis of non-frozen and frozen
iPSC-NS/PCs
Given the similarities between non-frozen and frozen-
hawed hiPSC-NS/PCs by the CAS in terms of proliferation andrchical clustering in the same samples. There was a distinct difference in the gene
. The gene expression proﬁles of non-frozen and frozen-thawed hiPSC-NS/PCs were
differentiation kinetics, we sought to perform detailed characteri-
zation of hiPSC-NS/PCs by transcriptome analysis. We performed
microarray analysis using a series of hiPSC-NS/PCs, which were
non-frozen hiPSC-NS/PCs, frozen-thawed hiPSC-NS/PCs by CAS,
frozen-thawed hiPSC-NS/PCs by freezing container, and hiPS cells,
as shown in Fig. 5. The samples of hiPSC-NS/PCs were harvested
at three and six days after the last passage. Frozen-thawed sam-
ples were obtained from two separate vials stored under the same
condition. We  performed principal component analysis (PCA) with
three principal components (PC1, 2 and 3) using the microarray
data. The contributions of each component were 25.97%, 21.09
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nd 7.91%, respectively. The samples of hiPS cells, frozen-thawed
iPSC-NS/PCs frozen at 3 and 6 days after the last passage were
learly separated, and samples of frozen-thawed hiPSC-NS/PCs
ere closely clustered with non-frozen sample in both freezing
iming (Fig. 5A). Two-dimensional hierarchical clustering revealed
hat the gene expression of frozen-thawed hiPSC-NS/PCs using the
AS and the freezing container formed a distinct cluster in both
reezing timing. Furthermore, the gene expression proﬁles of non-
rozen and frozen-thawed hiPSC-NS/PCs were closely clustered in
oth freezing timing (Fig. 5B). These ﬁndings suggest that freez-
ng and thawing by CAS or freezing container does not signiﬁcantly
ffect the cells’ gene expression proﬁles.
. Discussion
In this study, we validated the procedures for cryopreservation
f hiPSC-NS/PCs to apply them for future clinical application to
he CNS disorders and traumas. Although we  demonstrated the
ffectiveness of the CAS for clinical research settings, a series of
tudies has examined the impact of cryopreservation steps on var-
ous kinds of NS/PCs, including NS/PCs derived from mouse ESCs
Hancock et al., 2000), mouse fetal forebrain (Milosevic et al., 2005)
nd human fetal CNS (Vescovi et al., 1999). This series of studies
howed cell viability, cell fate determination and proliferation after
he freezing–thawing process, but to date there have been no stud-
es in which freezing protocols are directly compared in detail, nor
re there any guidelines governing the preservation of NS/PCs for
linical use, probably due to a lack of generalized procedures of
ryopreservation.
The two most commonly used methods of cryopreservation are
itriﬁcation and slow-freezing. Vitriﬁcation freezes cells quickly
y immersing into liquid nitrogen directly. Although ice crystal
ormation is completely prevented, vitriﬁcation requires a high
oncentration of cryoprotective agents, which is toxic to most cells
Fahy et al., 2004a,b; Fowler and Toner, 2005). In the actual clinical
etting, the cells for transplantation should be intensively washed
o remove the toxic reagent. Moreover, vitriﬁcation also requires
dditional special skills and is not suitable for large amounts of
ells (Fahy et al., 2004a,b; Fowler and Toner, 2005; Li et al., 2010;
eubinoff et al., 2001; Richards et al., 2004; Vajta and Nagy, 2006;
hou et al., 2004). Therefore, this procedure is not commonly
sed for clinical studies. In contrast, slow-freezing method had
n advantage in terms of handling and less-toxic reagent required
or the cryopreservation. Usually the cells are gradually frozen in
 deep freezer or programmed freezer with low concentration of
ryoprotective agents, which might not cause serious toxic and
smotic damage (Mazur, 1990). However, a large amount of ice
rystals formed inside the cells injure the cellular membrane. This
s explained by an insufﬁcient volume of cryoprotective agents to
revent ice crystal formation. If the penetration is too slow, cells
re exposed to the cryoprotective agents for a long time. As a result,
ells would be damaged (Al-Hasani et al., 2007; Balaban et al., 2008;
owler and Toner, 2005; Kuwayama et al., 2005; Paynter, 2008;
edro et al., 2005; Rama Raju et al., 2005). This technique does not
equire special skills and has allowed to freeze large amounts of
ells, but after thawing recovery is low compared with vitriﬁca-
ion (Imaizumi et al., 2014). Although these two  procedures have
oth merits and demerits, slow-freezing would be more advanced
ide for cell-banking because of the convenience and allowance of
reezing large amount of cells.
To improve cell survival in slow-freezing, at ﬁrst, we focused
n the cryopreservation solution, STEM CELL-BANKER, which is
hemically-deﬁned and xeno-free, making it suitable for clinical
pplication (Holm et al., 2010). It contains 10% DMSO, glucose
nd high polymer described in the Japanese Pharmacopeia (JP) asResearch 107 (2016) 20–29 27
a second cryoprotective agent plus NaCl, KCl, Na2HPO4, HK2PO4,
NaHCO3 as pH adjusters for maintenance of the cell function (Holm
et al., 2010).
We next focused on the freezing method, temperature, the num-
ber of frozen cells and the timing of cryopreservation (it means the
diameter of neurospheres). The survival and quality of the cryo-
preserved materials are also issues in the food industry, and a
new cryopreservation technology called “Cells Alive System” (CAS)
that uses a newly programmed freezer system and a magnetic
ﬁeld, has been developed. When frozen foods are thawed, dam-
aged cells lose intracellular water and many compounds affecting
product ﬂavor. Because cells contain clusters of water molecules,
when cells freeze, clusters may  grow inside cells and damage
the cell membrane. However, alternating magnetic ﬁelds with an
induced electric ﬁeld generated by the CAS freezer causes cells and
water molecules to vibrate by a non-thermal mechanism. These
vibrations are ampliﬁed in concert with mechanical and thermal
vibrations (CAS vibration), which prevents the formation of intra-
cellular ice crystals (Kaku et al., 2010, 2012, 2015). This effect has
been veriﬁed by scanning electron microscope (SEM) images which
show the miniaturization of intracellular ice crystals by use of
CAS freezer (Owada, 2011). Further, Iwasaka et al. (2011) reported
that ﬁne ice crystals, which strongly scatter the irradiating light,
increased in the early phase of the super-cooling state when a
pulsed train magnetic ﬁeld was applied. Previous reports showed
the successful cryopreservation and transplantation of periodon-
tal ligament cells using the CAS (Abedini et al., 2011; Kaku et al.,
2010, 2015). Additionally, murine osteoblasts, rat bones, rat MSCs
and human embryonic stem cells were cryopreserved by the CAS
programmed freezer (Kaku et al., 2014; Kojima et al., 2013, 2015;
Koseki et al., 2013; Lin et al., 2013). They reported CAS improved
cell survival and cryopreserved cells had as same function as non-
frozen cells.
We found that the best viability was 66.6% when the hiPSC-
NS/PCs were frozen at 2 × 106 cells/ml at 6 days after the last
passage using CAS under 0.4 A (0.30–0.40 mT)  condition by slow-
freezing, whereas it was 34.0% using freezing container. Cell
viability was superior when frozen at a density of 2 × 106 cells/ml
than 5 × 106 cells/ml. We  thought that the temperature did not
become uniform when the cell density was  too high. Some neu-
rospheres could not be sufﬁciently cooled, and were damaged as a
result. We assessed a fewer number of hiPSC-NS/PCs, the survival
was extremely low (data not shown). There may  thus be an optimal
cell density during freezing.
It is also better to be frozen at six days after the last passage
than 3 days after the last passage. The diameter of neurospheres at
three and six days was  54.7 ± 1.1 and 80.2 ± 2.9 m,  respectively.
We thought that penetration of the cryopreservation solution to
neurospheres was  insufﬁcient when the diameter of neurospheres
was too large. As a result, the cells would die. When we assessed
larger neurospheres, survival was  extremely low (data not shown).
There should thus be an optimal diameter of the neurospheres in
the freezing process. A previous study by Ma  et al. (2010) reported
that the sphere diameters might affect the survival rate, supporting
our present ﬁndings.
One might have interests on the mechanistic insight regulat-
ing improved survival rate achieved in the CAS system. Since we
found the signiﬁcant difference in the diameter of neurospheres
after thawing between using CAS and freezing container, we  specu-
lated the difference was  due to cell death caused by the mechanical
stress of freezing and thawing. As described above, CAS gener-
ates the alternating magnetic ﬁelds, which causes cells and water
molecules to vibrate. This CAS vibration prevents the formation
of intracellular ice crystals and damaging the cell membrane. In
our microarray analysis, there are only a few cell-death associated
genes changed between the cells frozen using CAS and ones using
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reezing container and therefore, molecular mechanism regulating
he cell survival by the CAS cannot be simply explained by trans-
riptome analysis. The detailed molecular mechanism underlying
he CAS system need to be unraveled in the future study.
In the present study, we showed an improvement in cell via-
ility using CAS under speciﬁc conditions. There was  signiﬁcant
ifference in the cell viability among the different CAS conditions
0.4 A and 0.3 A) and the freezing container. We  determined 0.4 A
0.30–0.40 mT)  condition of the CAS would be optimal for cryopres-
rvation of hiPSC-NS/PCs.
In terms of proliferation and differentiation ability, CAS had no
igniﬁcant effect on cell proliferation or differentiation ability, con-
istent with previous reports (Abedini et al., 2011; Hancock et al.,
000; Kaku et al., 2010, 2014, 2015; Kojima et al., 2013, 2015;
oseki et al., 2013; Lin et al., 2013; Ma  et al., 2010; Milosevic et al.,
005; Paynter, 2008; Tan et al., 2007). Moreover, PCA and hier-
rchical clustering indicated that the gene expression proﬁles of
ells frozen and thawed cells using CAS or freezing container were
imilar to those of non-frozen cells.
. Conclusions
CAS cryopreservation dramatically improved cell survival
mmediately after thawing and did not signiﬁcantly affect prolifer-
tion, differentiation or gene expression. We  plan to cryopreserve
iPSC-NS/PCs in STEM CELL-BANKER by slow-freezing method
sing the CAS protocol described above and transplant cells
mmediately after thawing to SCI patients in future clinical
tudies.
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